Internal Medicine CME

Stay Current with Essential Internal Medicine CME

The UCSF Advances in Internal Medicine online CME course provides an expert review of the most recent clinical advances and current controversies. Clinically active faculty emphasize topics of clinical relevance — cardiology, geriatrics, endocrinology, general internal medicine, women’s health, infectious diseases, gastroenterology, hematology and oncology, neurology, rheumatology, and pulmonary disease.

Designed for practicing internists, family practitioners, and other primary care health professionals, this internal medicine continuing medical education program will help you to:

• Better manage common medical conditions such as diabetes, osteoporosis, obstructive lung disease, and obesity
• Bring your practice in line with current evidence and updated guidelines for ischemic heart disease, vaccinations, sexually transmitted infections, contraception, and stroke prevention
• Manage problems traditionally treated by specialists and recognize indications for referral for conditions such as heart failure, cirrhosis, advanced lung disease, allergies, common neurologic diagnoses, and side effects of modern cancer therapy

Expert Vascular Surgery and Vascular Medicine CME

Designed to help you establish a strong foundation in both performance and interpretation of vascular ultrasound, this online CME program was developed in conjunction with the medical and technical directors of the vascular labs at Massachusetts General Hospital and Brigham and Women’s Hospital, as well as esteemed faculty from Stanford University Hospital, University of Colorado, and Johns Hopkins Hospital.

The Clinical Approach to Vascular Ultrasound and RPVI Prep Course delivers practical examples and case presentations that will enhance your ability to apply knowledge in patient situations. Online continuing medical education lecture topics include:

• Fundamental lower extremity physiologic and imaging studies used to diagnose and treat peripheral artery disease
• Normal and abnormal anatomy and imaging of the subclavian and vertebral arteries
• Techniques and indications used to predict impending bypass graft failure
• General overview for diagnosing and characterizing deep vein thrombosis, pelvic congestions syndrome, May-Thurner syndrome and venous thoracic outlet syndrome
• Dynamic TCD studies and their resulting surgical interventions and follow-ups
• and more…

The BoardVitals Internal Medicine Board MOC Question Bank has over 700 Internal Medicine MOC targeted review questions. The program offers questions that are directly relevant to the exam: multiple choice questions (mostly focused around patient scenarios) with a single best answer.

BoardVitals Internal Medicine Board MOC Question Bank Features:
• Every question, answer, and explanation is categorized
• Percent correct by other internists on every question
• Content updated in 2015 targeted to the most recent ABIM Internal Medicine Blueprint

Target Audience:
Internists preparing for the American Board of Internal Medicine MOC Exam.

For over a quarter century, Cleveland Clinic has been at the forefront of continuing education regarding the treatment and management of diabetes. Its world class faculty has designed the 27th Annual Diabetes Therapeutics, Technology and Surgery to provide up-to-date reviews of strategies and research relevant to this disease and its complications. The goal of this activity is to increase practitioners’ competence and clinical performance in the management of type 1 and type 2 diabetes. A greater understanding of the disease and available treatment options will lead to better patient outcomes. Worth 8.5 AMA PRA Category I Credits™, this enduring material is designed for primary care physicians, endocrinologists, diabetes educators, nurses, nurse practitioners, physician assistants and dietitians, with NO POST TEST. Additionally, physicians can earn up to 8.5 ABIM MOC points for this activity.

In this online, self-learning activity:

Hereditary angioedema (HAE) is a rare, debilitating, and potentially life-threatening disease due to C1-inhibitor (C1-INH) deficiency with an estimated prevalence of 5,000 people in the U.S. and over 116,000 worldwide. HAE is characterized by recurrent edema, and the cutaneous attacks can be disabling, with the skin, gastrointestinal tract, and upper airways are most commonly affected. Patients are also under persistent risk of laryngeal swelling that may prove fatal if not treated in a timely manner. The disease is classified as: HAE with normal functional C1INH protein (previously known as type III HAE) or HAE due to a deficiency of C1INH protein, with the latter further distinguished either by deficiency in both concentrations and function of C1INH (type I) or by normal levels of dysfunctional C1INH (type II). Owing to its rarity and symptomatic overlap with other conditions, patients not uncommonly experience a diagnostic delay of 8 to 10 years, putting them at a higher risk of inappropriate treatment, morbidity, and mortality.

Target Audience:
HCPs including: allergists, immunologists, emergency medicine specialists, and internists; physician assistants, nurse practitioners, and pharmacists specializing in immunology; and any other HCPs who have an interest in or otherwise clinically encounter patients with HAE.

In this online, self-learning activity:

Alpha-mannosidosis (AM) is a rare recessive lysosomal storage disorder characterized by immune deficiency, facial and skeletal abnormalities, hearing impairment, and intellectual disability. It is caused by mutations in the MAN2B1 gene, leading to deficiency in alpha-mannosidase, a lysosomal enzyme involved in the oligosaccharide degradation pathway. While the exact prevalence of AM in the US is unknown, it has an estimated incidence of 1 in 500,000 live births worldwide. Laboratory indicators of AM often appear shortly after birth, followed by progression of clinical manifestations. While symptoms of AM vary considerably in individual presentations, three clinical subtypes have been identified (mild, moderate, and severe) and are used to guide disease prognosis and management. The current diagnostic algorithm for AM focuses on measuring alpha-mannosidase activity in leukocytes using colorimetry or fluorimetry. An alpha-mannosidase activity level of under 5% suggests AM, and a diagnosis is then confirmed with genetic sequencing.

In this online, self-learning activity:

Dravet syndrome (DS) is a rare form of early-onset epilepsy syndrome affecting between 1:16,000 and 1:46,000 and is associated with pleomorphic seizure activity, cognitive decline, motor, and behavior abnormalities. Sudden unexpected death in epilepsy is the cause of death in nearly half of the deaths in patients with DS, with the mean age of death 8.7 years old and 73% of deaths occurring before age 10. Seizures typically begin in the first year of age, with most occurring between months 5 and 8, and it is usually a prolonged, tonic-clonic (accounting for 52% of first seizures) or hemiclonic (35%) seizure. Environmental triggers or events, such as fever, acute stress, and physical exercise may precipitate seizures, and at least 85% of those who are clinically diagnosed with DS have variations in the SCN1A gene. Unfortunately, diagnosis is not uncommonly delayed until a patient 3 years of age or older, prior to which antiseizure medication selection may be suboptimal or ineffective, which may lead to seizure exacerbation, an increased risk of status epilepticus, and worse cognitive outcomes.

Myelin oligodendrocyte glycoprotein antibody disease (MOGAD) is a demyelinating, autoimmune condition affecting the central nervous system. MOGAD is characterized by the presence of autoantibodies directed against the MOG protein located on the surface of myelin sheaths surrounding nerve fibers in the CNS. The disease course may be monophasic or relapsing, and a progressive course is extremely rare, making the mortality rate fairly low (2.1%) compared to other neuroinflammatory diseases. It is a relatively new addition to the category of demyelinating diseases, and approximately 10,000 cases of MOGAD are estimated within the U.S.

GIBLIB is an on-demand streaming medical education platform where physicians and advanced practice providers go to learn and earn CME through convenient, high-quality educational content created by trusted experts from the world’s top hospitals.

With this purchase, you get a 1-year subscription to GIBLIB and the following features:

• Earn unlimited AMA PRA Category 1 Credits™
• Full library access to thousands of videos across all specialties
• Personalized and curated video recommendations
• Cross-device viewing on web and iOS
• New content released and available every week
• Create custom playlists that you can personally curate
• Bookmark videos for later viewing
• Take notes on specific content and review for later
• View transcripts of all videos, available in multiple languages

The management of critically ill patients with liver disease requires the expertise of a variety of healthcare providers from multiple disciplines. Cleveland Clinic addresses their multifaceted educational needs with the Interprofessional Approach to Liver Disease. Physicians, nurses and physician assistants will benefit from the latest strategies and evidence based management guidance from an expert faculty. Worth 14 AMA PRA Category I Credits™, with ANCC and AAPA accreditation provided as well. This enduring material also qualifies for 14 ABIM MOC points, with NO POST TEST.